can peripheral blood mrd monitoring supplement bone marrow monitoring?
Published 4 months ago • 118 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
2:27
mrd by mass spectrometry in the peripheral blood in myeloma
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
1:46
importance of mrd monitoring in all
-
3:44
new mrd monitoring techniques could be most accurate predictor of relapse in mm patients
-
2:23
the role of mrd monitoring using mfc for aml: a real-world study
-
1:06
the importance of mrd monitoring in patients with aml
-
1:05
identifying residual lscs that may evade standard mrd monitoring & lead to relapse in aml
-
4:15
diagnostic tools for wm and the importance of whole genome sequencing
-
2:09
mrd in multiple myeloma: prognosis, a clinical trial endpoint, and guiding treatment decisions
-
2:16
current and future treatment approaches for hr-mds
-
1:50
the possibility of using mrd status to drive treatment in aml
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
1:46
standardization mrd monitoring in clinical trials
-
1:39
minimal residual disease (mrd) monitoring for multiple myeloma is here to stay
-
3:13
is mrd monitoring prior to allograft standard in aml?
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
1:49
bringing precision medicine and mrd into clinical strategies
-
1:41
results from determination: rvd with or without asct
-
1:40
mrd as a marker for depth of remission in cll
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
2:13
the impact of mrd in apheresis product in patients with myeloma undergoing autosct
-
6:00
mrd in myeloma: the need for sensitive and standardized measures